It was previously reported that BBR treatment activated apoptosis enhancing procaspase-3 cleavage and therefore caspase-3 activity in several tumor cells [28,52,53,54], including U251 and U87-MG GBM cell lines [28,30]. Here, CASP3 is linked to glioblastoma.